Zenas BioPharma, Inc. · NASDAQ:ZBIO
Kiselak Tomas bought 150,000 Zenas BioPharma, Inc. shares (Form 4)
Traded Mar 31, 2026 · Filed Apr 1, 2026
On Mar 31, 2026, Kiselak Tomas (Director) bought 150,000 Zenas BioPharma, Inc. shares at US$20.00 for US$3M, leaving 2,359,025 shares. Filed Apr 1, 2026 (Form 4).
- Bought
- 150,000 shares
- Price
- US$20.00
- Value
- US$3M
- Holding after
- 2,359,025 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Buy | 150,000 | US$20.00 | 2,359,025 | Indirect |
Source
Related
- Zenas BioPharma, Inc.
- Kiselak Tomas
- Zenas BioPharma, Inc. shareholders
- Schedule 13G/A · Wellington Management Group LLP · Nov 16, 2026
- Schedule 13G/A · Xencor, Inc. · Nov 5, 2026
- Schedule 13G · BlackRock, Inc. · Oct 27, 2026
- Schedule 13G · Wellington Management Group LLP · Sep 8, 2026
- Schedule 13G/A · InnoCare Pharma Inc. · Sep 8, 2026